Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.
about
Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonistsDistinct BOLD fMRI Responses of Capsaicin-Induced Thermal Sensation Reveal Pain-Related Brain Activation in Nonhuman PrimatesDistinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates.The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeysNeuraxial opioid-induced itch and its pharmacological antagonismPharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeysCharacterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates.[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic PainEffects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory painCentral N/OFQ-NOP Receptor System in Pain Modulation.Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.Activation of membrane estrogen receptors attenuates opioid receptor-like1 receptor-mediated antinociception via an ERK-dependent non-genomic mechanismPharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonistDifferential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.Recently patented and promising ORL-1 ligands: where have we been and where are we going?Plasma concentrations of nociceptin/orphanin FQ: comparison of levels after general and neuraxial anesthesia for arthroscopic knee surgery.Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13).Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor ProfileNociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic
P2860
Q26852027-64B03ED4-4BE9-42FC-9EE3-A20994016C36Q27341866-67D91263-882A-4389-B362-1F8013D6358DQ30655924-2644F2AF-B5BE-4BAF-BE26-EF528DF9BEC9Q35026981-606E993D-E22A-4D42-85F7-EB5DAE5B2FBEQ35659494-540F5D01-0E86-4114-9DF7-ABF6C0A6FB5BQ35738904-44E5DEFA-8A93-4619-A6AB-00CA799F6C50Q35846195-5D7A01F0-55EE-4D17-9DE0-080026D62B24Q35865460-C660E88A-1013-4887-BEBC-A538519D2AD7Q36043728-E3310AF7-E1F8-4203-A2EA-0B65CD2D6A0DQ36296864-925528F2-B572-4CFD-BE92-1D68DCFE0DC8Q36603205-E9424380-63CE-40C5-A35E-676A69316C4FQ36638633-BA326677-65FE-44FB-884D-CE4919F806CBQ36849604-3B4473AB-AC27-4203-A9D7-549CB997C991Q36935325-9020D230-4478-4BAB-AA8F-693F19CCA884Q37094760-F10AF43A-21F9-4CE8-9F5C-138BF0DAE77EQ37211503-B802120E-44B9-4DE1-8319-BC332C55CFE6Q37264264-DE1B3604-DB1E-4E23-A75C-F64A5FD0E8EBQ37511488-651DFD13-DC0A-4BB7-BB18-B322C284DA66Q37591805-C4A43323-1AD4-4AEE-9810-2AFCFAA89D30Q37638416-F0376BD1-F603-49E6-A815-7DE996B94924Q37697788-1B8563AA-9BC9-4310-89BC-A112DDB7EFB7Q42196769-10E130FE-FDCC-45AC-AA5A-9B6345B0CDDDQ44341523-21133E1D-32D4-4977-B751-F33EBC0E9553Q57073139-205B0AD9-1457-4879-9A58-FAF058A058B3Q58545262-EE50FD39-D723-4050-931D-B8DE9A42C9AC
P2860
Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Long-lasting antinociceptive s ...... n FQ receptor agonist UFP-112.
@ast
Long-lasting antinociceptive s ...... n FQ receptor agonist UFP-112.
@en
type
label
Long-lasting antinociceptive s ...... n FQ receptor agonist UFP-112.
@ast
Long-lasting antinociceptive s ...... n FQ receptor agonist UFP-112.
@en
prefLabel
Long-lasting antinociceptive s ...... n FQ receptor agonist UFP-112.
@ast
Long-lasting antinociceptive s ...... n FQ receptor agonist UFP-112.
@en
P2860
P1433
P1476
Long-lasting antinociceptive s ...... n FQ receptor agonist UFP-112.
@en
P2093
Girolamo Calò
P2860
P304
P356
10.1016/J.PAIN.2009.10.026
P407
P577
2009-11-28T00:00:00Z